Cold & Cough Remedies - G20

  • G20
  • In the year 2024, the revenue generated in the Cold & Cough Remedies market market in G20 countries amounts to a staggering US$36.22bn.
  • This market is projected to experience a steady annual growth rate of 5.84% from 2024 to 2029 (CAGR 2024-2029).
  • When comparing the revenue generated in this market globally, it is noteworthy that the in the United States leads the pack with a substantial revenue of US$11,190.00m in 2024.
  • In terms of per capita revenue, in G20 countries generate US$7.28 per person in the year 2024.
  • This figure provides a valuable insight into the economic impact of the Cold & Cough Remedies market market on each individual within the G20 countries.
  • In the United States, the demand for natural and herbal cold & cough remedies is on the rise.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in G20 has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences:
Customers in the Cold & Cough Remedies market in G20 are increasingly seeking products that provide quick and effective relief from symptoms. With busy lifestyles and a desire to minimize downtime, consumers are looking for remedies that can alleviate their symptoms and allow them to continue with their daily activities. Convenience is also a key factor, with customers preferring products that are easy to use and can be taken on the go. Additionally, there is a growing demand for natural and herbal remedies as consumers become more conscious of the ingredients they are putting into their bodies.

Trends in the market:
One of the major trends in the Cold & Cough Remedies market in G20 is the increasing availability of over-the-counter (OTC) products. This has made it easier for consumers to access remedies without the need for a prescription, leading to greater convenience and affordability. Another trend is the rise of combination products, which offer multiple benefits in a single dosage. For example, cold and cough remedies that also provide pain relief or decongestant properties. This trend is driven by the desire for products that can address multiple symptoms simultaneously.

Local special circumstances:
Each country in the G20 has its own unique set of circumstances that influence the Cold & Cough Remedies market. For example, in some countries with colder climates, there may be a higher demand for these remedies due to the prevalence of cold and flu seasons. In countries with higher population densities, there may be a greater need for remedies that can help prevent the spread of illnesses. Additionally, cultural factors and traditional remedies may also play a role in shaping customer preferences and market dynamics.

Underlying macroeconomic factors:
The Cold & Cough Remedies market in G20 is influenced by several macroeconomic factors. One such factor is the overall health and wellness trends in each country. As consumers become more health-conscious, they are more likely to seek out remedies to alleviate their cold and cough symptoms. Additionally, economic factors such as disposable income levels and healthcare expenditure can also impact the market. In countries with higher disposable incomes, consumers may be more willing to spend on premium or branded remedies. Government regulations and policies related to healthcare and pharmaceuticals can also shape the market dynamics in each country.Overall, the Cold & Cough Remedies market in G20 is experiencing growth due to customer preferences for quick and convenient relief, trends in the market such as the availability of OTC products and combination remedies, local special circumstances, and underlying macroeconomic factors. As the market continues to evolve, it will be important for companies to stay attuned to these factors and adapt their strategies to meet the changing needs of customers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)